You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
愛美客(300896.SZ):收購韓國REGEN Biotech,Inc.公司控股權事項已完成國內政府部門所需的批準
格隆匯 04-08 09:20

格隆匯4月8日丨愛美客(300896.SZ)公佈,有關收購韓國REGEN Biotech,Inc.公司控股權事項,截至 2025 年 4 月 7 日,公司本次投資事項已經獲得北京市發展和改革委員會頒發的京發改(備)【2025】187 號的《項目備案通知書》,獲得北京市商務局頒發的境外投資證第 N1100202500204 號《企業境外投資證書》,獲得國家外匯管理局北京市分局的批準。

根據《企業境外投資管理辦法》(國家發展改革委令第11 號),北京市發展和改革委員會對公司併購 REGEN Biotech, Inc.(韓國(株)麗臻生物科技股份有限公司)85%股權項目予以備案。通知書有效期 2 年。

公司本次境外投資符合《境外投資管理辦法》(商務部令2014 年第3 號)有關規定,獲得北京市商務局頒發的《企業境外投資證書》,公司自領取本證書之日起 2 年內有效。

截止日前,公司本次收購項目已完成國內政府部門所需的批準,公司國際化進程進一步加快。公司將根據該事項的進展情況依法及時履行信息披露義務,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account